Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Christopher M. Acker"'
Autor:
Carlos G. Sanchez, Christopher M. Acker, Audrey Gray, Malini Varadarajan, Cheng Song, Nadire R. Cochran, Steven Paula, Alicia Lindeman, Shaojian An, Gregory McAllister, John Alford, John Reece-Hoyes, Carsten Russ, Lucas Craig, Ketthsy Capre, Christian Doherty, Gregory R. Hoffman, Sarah J. Luchansky, Manuela Polydoro, Ricardo Dolmetsch, Fiona Elwood
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Using an unbiased genome-wide CRISPR screen approach, Sanchez et al. identified modulators of endogenous tau protein. This study suggests that chromatin modifiers, neddylation, ubiquitination, and the mTOR pathways regulate overall levels of tau prot
Externí odkaz:
https://doaj.org/article/a6974f96fa3e43eca73250a0892da4a2
Autor:
Peter Davies, Scott Ferguson, Gogce Crynen, Benoit Mouzon, Christopher M. Acker, Corbin Bachmeier, Michael Mullan, William Stewart, Joseph O. Ojo, Fiona Crawford
Publikováno v:
Journal of Neurotrauma. 36:576-588
Tau pathology associated with chronic traumatic encephalopathy has been documented in the brains of individuals with a history of repetitive mild traumatic brain injury (r-mTBI). At this stage, the pathobiological role of tau in r-mTBI has not been e
Autor:
Peter Davies, Michael Mullan, Benoit Mouzon, Ghania Ait-Ghezala, Daniel Paris, William Stewart, Joseph O. Ojo, Corbin Bachmeier, Fiona Crawford, Christopher M. Acker, Gogce Crynen, Scott Ferguson
Publikováno v:
Annals of Clinical and Translational Neurology
Objective: Exposure to repetitive concussion, or mild traumatic brain injury (mTBI), has been linked with increased risk of long-term neurodegenerative changes, specifically chronic traumatic encephalopathy (CTE). To date, preclinical studies largely
Autor:
Fiona Crawford, Michael J. Mullan, Joseph-Olubunmi Ojo, Benoit Mouzon, Corbin Bachmeier, William Stewart, Christopher M. Acker, Austin Ferro, Peter Davies, Gogce Crynen
Publikováno v:
Annals of Neurology. 75:241-254
Objective: Traumatic brain injury (TBI) is a recognized risk factor for later development of neurodegenerative disease. However, the mechanisms contributing to neurodegeneration following TBI remain obscure. Methods: In this study, we have utilized a
Autor:
Valérie Vingtdeux, Philippe Marambaud, Peter Davies, Pallavi Chandakkar, Christopher M. Acker, Haitian Zhao
Publikováno v:
Molecular Medicine, Vol 22, Iss 1, Pp 841-849 (2016)
Strategies aimed at reducing cerebral accumulation of the amyloid-β (Aβ) peptides have therapeutic potential in Alzheimer’s disease (AD). Aβ immunization has proven to be effective at promoting Aβ clearance in animal models but adverse effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c394e7f109166ebc840780e50dc42cc
Publikováno v:
Journal of Alzheimer's Disease. 25:119-133
Several immunocytochemical studies have revealed that Abelson tyrosine kinase (c-Abl) is associated with both neuritic plaques and neurofibrillary tangles in the brains of patients with Alzheimer’s disease (AD). Additionally, c-Abl has been shown t
Publikováno v:
Journal of Alzheimer's Disease. 19:721-733
Tau is a microtubule-associated protein and a main component of neurofibrillary tangles, one of the pathologic hallmarks of Alzheimer’s disease. The paired helical filaments (PHF) that comprise neurofibrillary tangles contain an abnormally hyperpho
Autor:
Giuseppe Terracina, Peter Davies, Stefanie K. Forest, Joel B. Schachter, Xiaohai Wang, Cristina d'Abramo, Christopher M. Acker
Publikováno v:
Neurobiology of aging. 37
In the attempt to elucidate if the "peripheral sink hypothesis" could be a potential mechanism of action for tau removal in passive immunotherapy experiments, we have examined tau levels in serum of chronically injected JNPL3 and Tg4510 transgenic an
Autor:
J. Lewis, Heidy Jimenez, Z. Liu, M. Lesser, B.S. Greenwald, Christopher M. Acker, Jeremy Koppel, Peter Davies, Cristina d'Abramo, M. Azose, Justin Buthorn
Publikováno v:
Behavioural brain research. 275
Psychotic Alzheimer's disease (AD+P) is a rapidly progressive variant of AD associated with an increased burden of frontal tau pathology that affects up to 50% of those with AD, and is observed more commonly in females. To date, there are no safe and
Publikováno v:
Alzheimer's & Dementia. 9